Dr Adele Rowley
Dr Adele Rowley, PhD, FRSB - Mironid
Dr Adele Rowley, PhD, FRSB. A biologist by training, Adele has over 20 years of drug discovery experience in the pharmaceutical and biotechnology industry ...
Adele Rowley - Chief Scientific Officer - Mironid® Limited - LinkedIn
Adele Rowley · Chief Scientific Officer at Mironid® Limited · View mutual connections with Adele · Welcome back · Experience · Education · Websites.
Adele Rowley - Chief Scientific Officer at Mironid - The Org
Adele Rowley. Adele Rowley's profile ... Previous positions include Chief Operating Officer & Head of Preclinical Development at TopiVert Pharma, Director ...
Dr Neil Wilkie PhD · Dr Adele Rowley, PhD, FRSB · Dr Catherine (Cass) Kelleher · Dr David Henderson FRSB · Dr Julia Adam PhD · Professor Dave Adams PhD · Richard ...
Adele Rowley | TOPIVERT | Malta - OMICS International
Adele Rowley. Head of Preclinical Projects and IBD Program Leader ... Dr. Matthew. pediatrics. University of Virginia Health System; Charlottesville ...
Adele Rowley's research works | World Cancer Research Fund ...
... drive the initiation of DNA replication. The prereplicative state is characterized by an additional region of protection overlapping the ORC footprint. This ...
Other papers submitted by: Dr Adele Rowley - Dove Medical Press
Back to User profile » Dr Adele Rowley. Paper published by Dr Adele Rowley: Clinical Trial Report. A phase 2 randomized, double-masked, placebo-controlled ...
Adele Rowley - Rare & Genetic Kidney Disease Drug Development
Adele Rowley, Company: Mironid Ltd., Job title: Chief Scientific Officer, Seminars: Targeting cAMP in ADPKD by Small Molecule Activation of Long Form PDE4 ...
Adele Rowley's research works | WWF United Kingdom and other ...
... drive cyst formation in ADPKD, resulting in decreased cyst growth in vitro and in vivo. Here we present translational data demonstrating that LoAc® compound ...
106 Followers, 81 Following, 9 Posts - Adele Rowley (@adelesmithurst) on Instagram: ""
Mironid Presents Translational Data in Oral Presentation at the ...
The presentation, by Mironid Chief Scientific Officer Dr Adele Rowley, was ... drive cyst formation in ADPKD, resulting in decreased cyst growth in ...
966 Targeting cAMP in ADPKD by small molecule activation of long ...
#966 Targeting cAMP in ADPKD by small molecule activation of long form PDE4 enzymes. Adele Rowley , ... Medicine and Health · Nephrology · Books.
American Society of Nephrology | Kidney Week
... Medical Education and Research, Rochester, Minnesota, United States. Vicente E. Torres, MD, PhD. Rowley, Adele, Mironid Ltd, Glasgow, United Kingdom. Adele ...
Mironid Presents Translational Data at European Renal Association ...
Dr. Adele Rowley, Mironid's Chief Scientific Officer, delivered a presentation entitled 'Targeting cAMP in ADPKD by small molecule ...
Mironid Presents Translational Data in Oral Presentation at the ...
The presentation, by Mironid Chief Scientific Officer Dr Adele Rowley, was ... drive cyst formation in ADPKD, resulting in decreased cyst growth in ...
1w. Report this post; Close menu. Catherine (Cass) Kelleher, MD, our Chief Medical Officer, Adele Rowley, our Chief Scientific Officer, and ...
Applications of protein mass spectrometry in cell biology. (2000 ...
Applications of protein mass spectrometry in cell biology. Adele Rowley,Jyoti S. ... TL;DR: Practical aspects of the application of ... TL;DR: Proteomics ...
Yeast origin recognition complex is involved in DNA replication and ...
Adele Rowley, Janet Harwood & John F. X. Diffley. Research Institute of Molecular Pathology, Dr Bohr Gasse 7, 1030, Vienna, Austria. Kim ...
Mironid Ltd. - Drug pipelines, Patents, Clinical trials - Patsnap Synapse
The presentation, by Mironid Chief Scientific Officer Dr Adele Rowley, was entitled 'Targeting cAMP in ADPKD by small molecule activation of long form PDE4 ...
4th Rare and Genetic Kidney Disease Drug Development Summit
... Adele Rowley, Chief Scientific Officer, Mironid Ltd., David Feldman, Senior Medical Project Director, National Kidney Foundation, William Smoyer, VP ...